Master in Molecular Oncology
Universidad Rey Juan Carlos T
Key Information
Campus location
Languages
English
Study format
Blended, Distance Learning
Duration
1 year
Pace
Full time
Tuition fees
EUR 45 / per credit *
Application deadline
Request info
Earliest start date
Request info
* resident students, per credit, price; €84.07: non-resident students, per credit, price
Introduction
What knowledge will I acquire with this Master's?
The Master consists of 60 ECTS credits, which will be studied over an academic year, from October to June.
The academic training consists of two sections:
- Research section with a focus on molecular oncology, of 36 credits taught in the 1st and 2nd semester.
- Section for the development of the Master's Thesis, of 24 credits taught in the 2nd semester.
The research orientation of the Master will be based on the research projects, systematic reviews, and original studies carried out through the Master's Final Project. In addition, the research nature of the Master is justified through each and every one of the subjects that make up the academic program, all of them compulsory and aimed at the acquisition of research skills in the field of Molecular Oncology and Molecular Pathology of Oncological disease: Molecular bases of cancer (3 credits), Protooncogenes and oncogenes (3 credits), Tumor suppressor genes (3 credits), Cellular processes involved in carcinogenesis (3 credits), Molecular pathology techniques (3 credits), Molecular pathology in the solid tumor clinic (6 credits).
Is this degree official according to the regulations required by the European Higher Education Area?
Yes.
Recommended Profile
Due to being a highly specialized training program, the University Master's Degree in Molecular Oncology is aimed at students with a recommended entry profile.
The recommended entry profile is that of a graduate or doctor of Medicine performing or having completed a specialty in any of these areas: Oncology, Pathology, Hematology or Radiotherapy, or any other with a special link to Oncology. However, graduates, graduates, or doctors from disciplines in the area of Health Sciences with a special interest or professional link in the field of Oncology may also study the Master.
Objectives
The general objectives of the Master are:
- Offer the cutting-edge training in Molecular Oncology that the specialist in the oncology area requires in correspondence with the development of Health Sciences in the 21st century.
- Laying the foundations for an excellent clinical practice based on the results of the latest research and through the scientific mastery of the molecular bases of cancer.
Competences
Basic skills
- CB6 - Possess and understand the knowledge that provides a basis or opportunity to be original in the development and/or application of ideas, often in a research context
- CB7 - That students know how to apply the acquired knowledge and their ability to solve problems in new or little-known environments within broader (or multidisciplinary) contexts related to their area of study
- CB8 - That students are able to integrate knowledge and face the complexity of making judgments based on information that, being incomplete or limited, includes reflections on social and ethical responsibilities linked to the application of their knowledge and judgments
- CB9 - That students know how to communicate their conclusions and the knowledge and ultimate reasons that support them to specialized and non-specialized audiences in a clear and unambiguous way
- CB10 - That students possess the learning skills that allow them to continue studying in a way that will be largely self-directed or autonomous.
General competences
- CG01 - Having acquired the molecular knowledge that allows understanding the advances in science and, where appropriate, transferring them into strategies for diagnosis and treatment.
- CG02 - Having developed sufficient autonomy to participate in research projects and scientific or technological collaborations within their thematic scope, in interdisciplinary contexts, and, where appropriate, with a high component of knowledge transfer to clinical practice.
Transversal competences
- CT01 - Respect the differences of opinion of colleagues, teachers, and students.
- CT02 - Establish contacts with the network of students and teachers who are receiving the Master's training.
- CT03 - Promote the development of social networks in favor of the development of scientific collaboration activities in clinical practice and research.
Specific competences
- CE01 - Know the oncogenes, tumor suppressor genes, and the consequences of their alteration.
- CE02 - Establish the cellular processes involved in the repair of genetic damage and the mutating pathway in carcinogenesis.
- CE03 - Evaluate the relevance of applying new antitumor therapies in patients on a case-by-case basis.
- CE04 - Interpret the evolutionary results of pathological and histological studies indicated in cancer patients
- CE05 - Prepare an unpublished Research Report in the field of Oncology from the use of methods and techniques of scientific research in molecular oncology, with emphasis on translational oncology research.
- CE06 - Develop the ability to work in a group of peer professionals linked to oncology from the programmatic development of the knowledge of neoplastic pathology acquired in the Master.
- CE07 - Collaborate in the development and implementation of tools for the diagnosis and treatment of cancer patients using the knowledge acquired on cell biology, mechanisms of gene regulation, and changes caused by the neoplastic transformation.
- CE08 - Mastering the methodological strategies of clinical trials and the application of molecular targets as a complement to the diagnosis and prognosis of suspected cancer patients.
- CE09 - Actively use the vocabulary of Molecular Oncology, as well as the concepts of diagnosis and prognosis based on molecular bases, during the professional performance.
- CE10 - Use the knowledge about the molecular bases of cancer and research skills in oncology acquired in the Master's in favor of the development of science.
Admission
The requirements for access to the proposed degree are according to article 16, Royal Decree 1393/2007, modified by Royal Decree 861/2010, of July 2:
- To access the official Master's degrees, it will be necessary to hold an official Spanish university degree or another issued by a higher education institution belonging to another State that is part of the European Higher Education Area that empowers there to access teachings of Master.
- Likewise, graduates in accordance with educational systems outside the European Higher Education Area will be able to access without the need for homologation of their degrees, after verification by the University that they accredit a level of training equivalent to the corresponding official Spanish university degrees and that empower in the country issuing the degree for access to postgraduate education. Access by this means will not imply, in any case, the homologation of the previous degree that the interested party is in possession, nor its recognition for other purposes than that of taking the Master's degrees.
The Rey Juan Carlos University does not have specific admission regulations but is governed by article 16 of Royal Decree 1393/2007, modified by Royal Decree 861/2010, of July 2. Each title has its own general access criteria and special access tests.
Admission to the University Master's degrees will be made through a selection process; in some cases, this process may involve a screening test. The Directorate of the Master will communicate to the interested parties what the selection test will consist of, if any, as well as the exact date and the way of carrying it out through this application and by means of notice by mail electronic.
The enrollment of new students in the University Masters of the Rey Juan Carlos University is carried out, through the Internet, in the enrollment period whose dates are established and published on the University's website.
In the case of remaining vacancies in the University Master's degrees offered in the ordinary term pre-registration, a second extraordinary registration period is opened, after the corresponding pre-registration period, on the dates established in the month of September.
Offer of places: 150 places. If the minimum number of students foreseen is not reached in a course, the University may choose not to open the teaching group.
Training Itinerary
Code | Matter | ECTS number | Semester | Kind |
627201 | Molecular bases of cancer | 3 | First | required |
627202 | Proto-oncogenes and oncogenes | 3 | First | required |
627203 | Tumor suppressor genes | 3 | First | required |
627204 | Cellular processes involved in carcinogenesis | 3 | First | required |
627205 | Molecular pathology techniques | 3 | First | required |
627206 | Molecular pathology in the clinic of solid tumors | 6 | First | required |
627207 | Molecular pathology in the clinic of hematological tumors | 3 | First | required |
627208 | Clinical Research Methodology in Oncology | 3 | First | required |
627209 | Risk factors in neoplasms | 3 | First | required |
627210 | Pharmacology and antitumor agents | 3 | Second | required |
627211 | New molecular therapies | 3 | Second | required |
627212 | Final Master's Project | 24 | Second | required |